A study based on online datasets indicated that high REDD1 expression was significantly associated with a worse prognosis in acute myeloid leukemia, breast cancer, glioblastoma multiforme, and colon, skin, and lung cancer [19]. This evidence concerns the gene DDIT4 and breast carcinoma.